Eight patients were studied to determine the changes in pancuronium requirements during hypothermic cardiopulmonary bypass. They were anaesthetised with fentanyl as the principal agent, ventilated with oxygen and the neuromuscular junction was monitored using train-of-four stimulation. After a bolus dose of pancuronium an infusion was used to maintain the first twitch of the train-of-four at 5-15 per cent of control. Before bypass the mean pancuronium infusion rate was 0.52 (SD 0.16) JJ.glkglmin. There was a small, brief increase in requirement with the initiation of bypass to 0.62 (SD 0.38) JJ.glkglmin, which was folio wed by a decrease of more than 80 per cent during hypothermia to 0.08 (SD 0.03) JJ.glkglmin. Rewarming was associated with a rapid increase in requirement to 0.64 (SD 0.17) JJ.glkglmin, which decreased to 0.33 (SD 0.23) JJ.glkglmin when normothermia was re-established.
The dose requirements for neuromuscular blocking drugs during operations involving cardiopulmonary bypass have received little attention. Although it is desirable to obtund respiratory efforts the need for profound relaxation is limited. Traditionally these patients have been ventilated postoperatively until cardiovascular stability was assured and the persisting effects of relaxants or narcotics were obviated. Recently there has been a trend towards early extubation of these patients.! Thus, it is appropriate to re-examine the requirements for neuromuscular blocking drugs which might vary during cardiopulmonary bypass. Initiation of cardiopulmonary bypass causes an increase in the volume of distribution with a decrease of plasma concentration of neuromuscular blocking drugs and hence a tendency of neuromuscular function to recover. However, during the hypothermic period of bypass, cooling decreases plasma clearance 2 and increases the sensitivity of the neuromuscular junction to pancuronium. 2 ,3,4 Thus the requirement for neuromuscular blocking drugs would be reduced.
Previous studies of neuromuscular blocking drugs and neuromuscular function with cardiopulmonary bypass have investigated these effects in part. Park 4 and Conrad 5 showed that recovery of an indirectly elicited muscle twitch was accelerated with initiation of bypass and during rewarming, but was absent during the period of hypothermia. Neither study attempted to quantitate relaxant requirements or maintain a steady level of block, Shanks 6 studied the clearance of d-tubocurarine during cardiopulmonary bypass and found it was decreased although the temperatures during the study were not stated and the activity of the neuromuscular junction was not measured.
Miller et al. quantitated the decreased requirement for pancuronium during hypothermia in cats 2 ,7 but admitted that species variability occurred. s Therefore this study was undertaken to investigate the combined effects of cardiopulmonary bypass and hypothermia on the pancuronium requirements to maintain constant neuromuscular block in man.
METHODS
The protocol was approved by the hospital ethics committee. Eight patients without known or suspected renal or hepatic disease, undergoing cardiac surgery with hypothermic cardiopulmonary bypass, were studied. Premedication consisted of oral diazepam (7.5-10 mg) and intramuscular morphine (5-10 mg) and hyoscine (0.3-0.4 mg). Following the administration of oxygen by face mask fentanyl 40-80 JAg/kg was given slowly intravenously. When anaesthesia was judged to be adequate, stimulation of the ulnar nerve at the elbow with subcutaneous needle electrodes was begun. Four supramaximal square wave impulses of 0.2 ms duration and 2 Hz frequency were administered every 12 seconds using a Grass S48 stimulator and SIU5 isolation unit. The force of contraction of the adductor pollicis muscle was measured with a Grass FTIO force displacement transducer and recorded on a Grass polygraph pen and ink recorder. When control recordings had been made a bolus of pancuronium (0.06-0.09 JAg/kg) was given to facilitate intubation. When the height of the first twitch of the train-of-four (Tl) had returned to 5-10 per cent of control a pancuronium infusion (0.04 mg/ml in 5 per cent dextrose) was begun and run at a rate which maintained twitch height at 5-15 per cent of control.
The patient was ventilated to normocapnia using a modified T-piece, the end-tidal carbon dioxide tension being measured with a Hewlett Packard HP capnograph. When necessary anaesthesia was supplemented with nitrous oxide, droperidol, or additional fentanyl. The nasopharyngeal and thenar skin temperatures Anaesthesia and Intensive Care, Vol. 11. No. 3, AuguSl. /983 were monitored as well as direct radial artery and pulmonary artery pressures, arterial blood gas tensions, electrocardiogram, serum potassium concentrations and urinary output.
After starting the infusion the pancuronium requirements of each patient were assessed during five periods: 1. normothermia, precardiopulmonary bypass; 2. initiation of bypass and cooling; 3. steady hypothermia on bypass; 4. rewarming; 5 normothermia, where both nasopharyngeal and skin temperatures were similar to those in period 1.
The pump prime consisted of Ringer lactate (1500 ml); salt-poor albumen (200 ml of 25 per cent) and sodium bicarbonate (44 mEq in 50 ml). Mean values are presented with the standard deviation as the index of dispersion.
Where applicable Student's paired t test was used, the null hypothesis being rejected when p < 0.05. In addition the Wilcoxon rank sign test was used to identify significant trends in first twitch tension which did not progress because the pancuronium infusion rate was altered.
RESULTS
The average age of the seven men and one woman was 59 years (range 50-66 years); their average weight was 68.5 kg (range 49-92 kg) and surface area 1.64 sq m (range 1.34-1.90).
The pancuronium infusion was started 35 (SD 17) minutes after the initial bolus and continued for 172 (SD 11) minutes. The duration, temperature and infusion rate during each of the five periods of the infusion are shown in Table 1 .
The mean infusion rate during period 1 was 0.52 (SD 0.16) JAg/kg/min and increased insignificantly in period 2 to 0.62 (SD 0.33) JAg/kg/min. In the first 5-10 min of period 2 every patient showed a slight increase, 9.9 (SD 4.3) per cent of control, in T1 (p < 0.01) before temporary increases of the infusion rate returned the height of T1 to 5-15 per cent of the control. During period 3, at a mean temperature of 26.2 (SD 0.9) QC, the infusion rate decreased by 84 per cent from that in period 1.
In period 4, Tl tended to recover in every patient (p < 0.01) by 11.9 (SD 7.6) per cent of control Tl, before increased infusion rates brought its height back to 5-15 per cent of control. Despite regaining normothermia in * Significantly less than all other periods. p < 0.05-< 0.001 ** Significantly greater than periods 3 and 5. p < 0.001 and p < 0.01 *"Significantly less than periods I, 2 and 4. p < 0.05-< 0.01 period 5 the infusion rates were less (p < 0.05) than in period 1. DISCUSSION Agoston and his colleagues 9 concluded that the concentration of pancuronium necessary for a given degree of neuromuscular block was best evaluated by the use of a continuous infusion technique. We have found that the combination of an infusion and continuous monitoring of the neuromuscular junction allows a constant level of neuromuscular block to be maintained because the rate of infusion can be adjusted rapidly to match changing drug requirements. Thus, in situations where several factors occur simultaneously to modify neuromuscular blocking drug requirement, e.g. cardiopulmonary bypass, the net result of these different effects can be recognised by a change in the required infusion rate.
During the pre-bypass period mean infusion rate required to maintain the first twitch of the train of four at 5-15 per cent of control was similar to that described by Miller and Eger J O using pancuronium infusions of a similar duration. A slight increase in infusion rate was necessary during the first 5 to 10 minutes of bypass, presumably to counteract the diluting effect of the pump prime. However, the most dramatic change in neuromuscular blocking drug requirement was the decrease by 84 per cent during the hypothermic bypass period. This was probably the result of decreased pancuronium clearance 2 and an increased sensitivity of the neuromuscular junction to pancuronium 2 • 7 induced by hypothermia. Park and Macnamara 4 drew similar conclusions after they noticed a decrease in twitch height from 25 to 17 per cent without additional relaxant during bypass but their methodology did not allow the magnitude of the decrease of pancuronium requirement to be recognised. Miller established that when the body temperature was reduced from 38 to 29°C this was associated with a 50 per cent decrease in the plasma pancuronium concentration required to maintain 50 per cent neuromuscular block. 2 Recovery of neuromuscular activity during rewarming 4 • 5 was prevented by an increase in pancuronium infusion rate which was significantly greater than in the normothermic period which followed. This suggests that, in addition to meeting the demands of increased clearance, further pancuronium was required to re-establish an effective plasma concentration which had decreased during hypothermia.
When normothermia was established after bypass the pancuronium requirement was significantly less than during the pre-bypass period and this may have several causes. A steady state may not have existed in the prebypass period although Miller and Eger's studyl° with a similar regimen and time sequence would not support this. Rewarming of the muscle may have been incomplete but the temperature of the skin overlying the hand muscles had returned to control value. Finally, and most likely, renal and hepatic clearances of pancuronium may be decreased immediately after bypass.
In summary, this study quantified the marked changes in pancuronium requirements during hypothermic cardiopulmonary bypass. Relaxant supplements during rewarming would seem to be more important than those upon initiation of bypass if a steady level of neuromuscular block is to be maintained throughout the operation.
